Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial

Author:

Laffel Lori M,Danne Thomas,Klingensmith Georgeanna J,Tamborlane William V,Willi Steven,Zeitler Philip,Neubacher Dietmar,Marquard Jan,Bardymova Tatiana,Barrientos Perez Margarita,Bethin Kathleen,Bjornstad Petter,Bondar Irina,Chen Mimi,Choi Jin-Ho,Clements Mark A,Colomar Javier Ricardo,Daniels Mark,Deerochanawong Chaicharn,Desai Vivek S,Desmangles Jean-Claude G,Dillon Robert G,Dixit Naznin M,Du Hongwei,Edelen Rachel,Espinoza Peralta Diego,Felipe Gacioppo María Verónica,Ferraz Tania Maria Bulcão Lousada,Galkina Galina,Gallagher Mary Patricia,George Minu,Gonzalez Edgar,Gottschalk Michael Everett,Guido Giancarlo,Hassan Amir Ali,Hershkovitz Eli,Huerta-Saenz Lina P,Hwang Jin Soon,Ibarra Gomez Jaime Orlando,Irizarry Gonzalez Lydia,Jain Nina,Jelley David H,Kim Ho-Seong,Kovalenko Tatiana,Laffel Lori Michelle B,Leichter Steven B,Liberatore Jr Raphael Del Roio,Lynch Jane,Mahmud Farid Hussain,Malievskiy Oleg Arturovich,Muir Andrew,Nelson Bryce A,Nevarez Ruiz Luis Alejandro,Olson Micah L,Pelayo Orozco Emilia Susana,Peterkova Valentina,Ramírez Mendoza Fernando Ramón,Reddy Konda Mohan,Rodriguez Henry,Saenz Javier Andres,Samoilova Julia,Schwab Karl-Otfried,Shah Sejal H,Shehadeh Naim,Shoemaker Ashley H,Skorodok Yulia,Sobolev Aleksandr,Solís Silvana Ernestina,Srinivasan Shylaja,Tamborlane William V,Tsalikian Eva,Valeeva Farida,Vance Carl D,Velasquez-Mieyer Pedro A,Violante Ortiz Rafael Margarito,Votyakova Olga,Wei Haiyan,Weinstock Ruth S,Wheeler Mark D,Wicklow Brandy Alexandra,Willi Steven M,Wintergerst Kupper A,Wolf Risa M,Wood Jamie Ruth,Yaliwal Chandan,Yupanqui Lozno Hernán

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3